Fundraising September 15, 2024 – October 1, 2024 About fundraising

Tailored NEOadjuvant epirubicin, cyclophosphamide and...

Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial—Clinical outcomes and molecular determinants of response

Murphy, Caitlin, Muscat, Andrea, Ashley, David, Mukaro, Violet, West, Linda, Liao, Yang, Chisanga, David, Shi, Wei, Collins, Ian, Baron-Hay, Sally, Patil, Sujata, Lindeman, Geoffrey, Khasraw, Mustafa,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0210891
Date:
February, 2019
File:
PDF, 1.50 MB
2019
Conversion to is in progress
Conversion to is failed